1
|
Miranda-Filho A, Piñeros M and Bray F: The
descriptive epidemiology of lung cancer and tobacco control: A
global overview 2018. Salud Publica Mex. 61:219–229. 2019.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Li J, Zhu H, Sun L, Xu W and Wang X:
Prognostic value of site-specific metastases in lung cancer: A
population based study. J Cancer. 10:3079–3086. 2019. View Article : Google Scholar : PubMed/NCBI
|
3
|
Zhao W, Yu H, Han Z, Gao N, Xue J and Wang
Y: Clinical significance of joint detection of serum CEA, SCCA, and
bFGF in the diagnosis of lung cancer. Int J Clin Exp Pathol.
8:9506–9511. 2015.PubMed/NCBI
|
4
|
Fu L, Wang R, Yin L, Shang X, Zhang R and
Zhang P: CYFRA21-1 tests in the diagnosis of non-small cell lung
cancer: A meta-analysis. Int J Biol Markers. 34:251–261. 2019.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Qin K, Chen Y, Long H, Chen J, Wang D,
Chen L and Liang Z: The biomarkers and potential pathogenesis of
lung cancer related cerebral hemorrhage. Medicine (Baltimore).
98:e156932019. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ogawa M, Mizugishi K, Ishiguro A, Koyabu
Y, Imai Y, Takahashi R, Mikoshiba K and Aruga J: Rines/RNF180, a
novel RING finger gene-encoded product, is a membrane-bound
ubiquitin ligase. Genes Cells. 13:397–409. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Zhang X, Zhang X, Sun B, Lu H, Wang D,
Yuan X and Huang Z: Detection of aberrant promoter methylation of
RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric
cancer. Oncol Lett. 8:1745–1750. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Han F, Sun LP, Liu S, Xu Q, Liang QY,
Zhang Z, Cao HC, Yu J, Fan DM, Nie YZ, et al: Promoter methylation
of RNF180 is associated with H. pylori infection and serves
as a marker for gastric cancer and atrophic gastritis. Oncotarget.
7:24800–24809. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Cheung KF, Lam CN, Wu K, Ng EK, Chong WW,
Cheng AS, To KF, Fan D, Sung JJ and Yu J: Characterization of the
gene structure, functional significance, and clinical application
of RNF180, a novel gene in gastric cancer. Cancer. 118:947–959.
2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Deng J, Liang H, Zhang R, Hou Y, Liu Y,
Ying G, Pan Y and Hao X: Clinical and experimental role of ring
finger protein 180 on lymph node metastasis and survival in gastric
cancer. Br J Surg. 103:407–416. 2016. View Article : Google Scholar : PubMed/NCBI
|
11
|
Udali S, Guarini P, Ruzzenente A,
Ferrarini A, Guglielmi A, Lotto V, Tononi P, Pattini P, Moruzzi S,
Campagnaro T, et al: DNA methylation and gene expression profiles
show novel regulatory pathways in hepatocellular carcinoma. Clin
Epigenetics. 7:432015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Han F, Liu S, Jing J, Li H, Yuan Y and Sun
LP: Identification of high-frequency methylation sites in RNF180
promoter region affecting expression and their relationship with
prognosis of gastric cancer. Cancer Manag Res. 12:3389–3399. 2020.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Akhurst T: Staging of non-small-cell lung
cancer. PET Clin. 13:1–10. 2018. View Article : Google Scholar : PubMed/NCBI
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Ottis P, Toure M, Cromm PM, Ko E,
Gustafson JL and Crews CM: Assessing different E3 ligases for small
molecule induced protein ubiquitination and degradation. ACS Chem
Biol. 12:2570–2578. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ning Y, Hui N, Qing B, Zhuo Y, Sun W, Du
Y, Liu S, Liu K and Zhou J: ZCCHC10 suppresses lung cancer
progression and cisplatin resistance by attenuating MDM2-mediated
p53 ubiquitination and degradation. Cell Death Dis. 10:4142019.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Deng J, Guo J, Guo X, Hou Y, Xie X, Sun C,
Zhang R, Yu X and Liang H: Mediation of the malignant biological
characteristics of gastric cancer cells by the methylated CpG
islands in RNF180 DNA promoter. Oncotarget. 7:43461–43474. 2016.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Potabattula R, Dittrich M, Schorsch M,
Hahn T, Haaf T and El Hajj N: Male obesity effects on sperm and
next-generation cord blood DNA methylation. PLoS One.
14:e02186152019. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yang ZH, Dang YQ and Ji G: Role of
epigenetics in transformation of inflammation into colorectal
cancer. World J Gastroenterol. 25:2863–2877. 2019. View Article : Google Scholar : PubMed/NCBI
|
20
|
Sutton LP, Jeffreys SA, Phillips JL,
Taberlay PC, Holloway AF, Ambrose M, Joo JE, Young A, Berry R,
Skala M, et al: DNA methylation changes following DNA damage in
prostate cancer cells. Epigenetics. 14:989–1002. 2019. View Article : Google Scholar : PubMed/NCBI
|
21
|
Xie XM, Deng JY, Hou YC, Cui JL, Wu WP,
Ying GG, Dong QP, Hao XS and Liang H: Evaluating the clinical
feasibility: The direct bisulfite genomic sequencing for
examination of methylated status of E3 ubiquitin ligase RNF180 DNA
promoter to predict the survival of gastric cancer. Cancer Biomark.
15:259–265. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Deng J, Liang H, Zhang R, Ying G, Xie X,
Yu J, Fan D and Hao X: Methylated CpG site count of dapper homolog
1 (DACT1) promoter prediction the poor survival of gastric cancer.
Am J Cancer Res. 4:518–527. 2014.PubMed/NCBI
|
23
|
Deng J, Liang H, Ying G, Li H, Xie X, Yu
J, Fan D and Hao X: Methylation of ras association domain protein
10 (RASSF10) promoter negative association with the survival of
gastric cancer. Am J Cancer Res. 4:916–923. 2014.PubMed/NCBI
|
24
|
Paun O, Verhoeven KJF and Richards CL:
Opportunities and limitations of reduced representation bisulfite
sequencing in plant ecological epigenomics. New Phytol.
221:738–742. 2019. View Article : Google Scholar : PubMed/NCBI
|